Clinical Trial

BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function

Study acronym: BETAMI
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The study aims to investigate whether oral betablocker (BB) therapy is superior to no such treatment following an acute myocardial infarction (AMI).
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2018-08-23; most recent amendment 2025-06-04.
Status change: Recruiting → Active, Not Recruiting 2024-02-29
Status change: Not Yet Recruiting → Recruiting 2018-10-01
Trial Details
NCT Number NCT03646357
Lead Sponsor Oslo University Hospital
Collaborators: Vestre Viken Hospital Trust, The Hospital of Vestfold, University of Oslo, Helse Stavanger HF, Haukeland University Hospital, St. Olavs Hospital, University Hospital of North Norway, Sorlandet Hospital HF, Norwegian University of Science and Technology, Sykehuset Innlandet HF, Nordlandssykehuset HF, Lovisenberg Diakonale Hospital, Diakonhjemmet Hospital, Ostfold Hospital Trust
Conditions Acute Myocardial Infarction, Non-ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction
Enrollment 2,895 participants
Start Date 2018-10-01
Primary Completion 2025-04-04 (estimated)
Study Completion 2035-12-10 (estimated)
Updated on ClinicalTrials.gov 2025-06-08